Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation.

Saved in:
Bibliographic Details
Title: Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation.
Authors: Kakani, Pragya1 pka4006@med.cornell.edu, Katcher, Bradley A.2, Maini, Luca3
Source: Health Affairs. Nov2025, Vol. 44 Issue 11, p1417-1425. 9p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first